Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries

Francis J. Crosson; Jon B. Christianson

doi:10.1001/jamainternmed.2018.6146

Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries

Health Policy and Management

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	380-382
Number of pages	3
Journal	JAMA internal medicine
Volume	179
Issue number	3
DOIs	https://doi.org/10.1001/jamainternmed.2018.6146
State	Published - Mar 2019

PubMed: MeSH publication types

Journal Article
Comment

Access

10.1001/jamainternmed.2018.6146

OpenUrl availability

Full text

Cite this

@article{ebd9cd1678b6448fba514668c5639749,

title = "Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries",

author = "Crosson, {Francis J.} and Christianson, {Jon B.}",

year = "2019",

month = mar,

doi = "10.1001/jamainternmed.2018.6146",

language = "English (US)",

volume = "179",

pages = "380--382",

journal = "JAMA internal medicine",

issn = "2168-6106",

publisher = "American Medical Association",

number = "3",

}

TY - JOUR

T1 - Managing the Cost of Medicare Part B Drugs

T2 - Implications for the Program and Beneficiaries

AU - Crosson, Francis J.

AU - Christianson, Jon B.

PY - 2019/3

Y1 - 2019/3

UR - http://www.scopus.com/inward/record.url?scp=85059941889&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85059941889&partnerID=8YFLogxK

U2 - 10.1001/jamainternmed.2018.6146

DO - 10.1001/jamainternmed.2018.6146

M3 - Comment/debate

C2 - 30640365

AN - SCOPUS:85059941889

SN - 2168-6106

VL - 179

SP - 380

EP - 382

JO - JAMA internal medicine

JF - JAMA internal medicine

IS - 3

ER -

Managing the Cost of Medicare Part B Drugs: Implications for the Program and Beneficiaries

PubMed: MeSH publication types

Access

OpenUrl availability

Other files and links

Cite this